(Total Views: 100)
Posted On: 08/12/2024 1:16:05 PM
Post# of 38429
CS Diagnostics (OTC: FZRO) Moves Forward with 2024 Expansion, Announces Major Acquisitions and Landmark Deal
CS Diagnostics Group (OTC: FZRO) signed a landmark agreement to sell and transfer tangible and intangible assets, including patents, for the CS Protect-Hydrogel to CS Diagnostics Corp. The hydrogel-based tissue spacer, designed for radiation therapy, increases the distance between healthy tissue and cancer cells, protecting healthy tissues from high radiation doses.
Full Details Here https://www.marketscreener.com/quote/stock/CS...-47554520/
CS Diagnostics Group (OTC: FZRO) signed a landmark agreement to sell and transfer tangible and intangible assets, including patents, for the CS Protect-Hydrogel to CS Diagnostics Corp. The hydrogel-based tissue spacer, designed for radiation therapy, increases the distance between healthy tissue and cancer cells, protecting healthy tissues from high radiation doses.
Full Details Here https://www.marketscreener.com/quote/stock/CS...-47554520/
(0)
(0)
